Literatur
-
1
Apelqvist J, Ragnarsson-Tennvall G, Persson U, Larsson J.
Diabetic foot ulcers in a multidisciplinary setting an economic analysis of primary healing and healing with amputation.
J Int Med.
1994;
235
463-471
-
2
Armstrong DG, Salas P, Short B, Martin BR. et al. .
Maggot therapy in „lower-extremity hospice” wound care: fewer amputations and more antibiotic-free days.
J Am Podiatr Med Assoc.
2005;
95
254-257
-
3
Armstrong DG, Lavery LA.
Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomized controlled trail.
Lancet.
2005;
366
1704-1710
-
4
Chantelau E, Breuer U, Leisch AC.
Outpatient treatment of unilateral diabetic foot ulcers with half shoes.
Diabetic Med.
1993;
10
267-279
-
5
DECODE Study Group .
Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.
Arch Intern Med.
2001;
161
397-405
-
6
Ha G Van, Siney H, Hartmann-Heurtier A, Jacqueminet S. et al. .
Nonremovable, windowed, fibreglass cast boot in the treatment of diabetic plantar ulcers: efficacy, safety, and compliance.
Diabetes Care.
2003;
26
2848-2852
-
7
Heller G, Günster C, Schellschmidt H.
Wie häufig sind Diabetes-bedingte Amputationen unterer Extremitäten in Deutschland? Eine Analyse auf Basis von Routine-Daten.
Dtsch Med Wochenschr.
2004;
129
429-433
-
8 International Consensus Working Group .International consensus on diagnosing and treating the infected diabetic foot. 2003
-
9
Faglia E, Dalla L Paola, Clerici G. et al. .
Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003.
Eur J Vasc Endovasc Surg.
2005;
29
620-627
-
10
Gaede P, Vedel P, Larsen NJ. et al. .
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
N Engl J Med.
2003;
348
383-393
-
11
Lavery LA, Houtum WH Van, Armstrong DG.
Institutionalisation following diabetes-related lower extremity amputation.
Am J Med.
1997;
103
383-388
-
12
Luther M, Lepantalo M.
Arterial reconstruction to the foot arteries-a viable option?.
Eur J Surg.
1997;
163
659-665
-
13
Morbach S, Müller E, Reike H. et al. .
Evidenzbasierte Leitlinien: Diagnostik, Therapie, Verlaufskontrolle und Prävention des diabetischen Fußsyndroms.
Diabetes u. Stoffwechsel.
2004;
13
9-30
-
14
Oyibo SO, Jude EB, Tarawneh I. et al. .
A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems.
Diabetic Care.
2001;
24
84-88
-
15
Prompers L, Huijberts M, Apelqvist J. et al. .
High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study.
Diabetologia.
2007;
50
18-25
-
16
Sherman RA.
Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy.
Diabetes Care.
2003;
26
446-451
-
17
Stiegler H, Diehm C, Grom E. et al. .
Placebokontrollierte, doppelblinde Studie zur Wirksamkeit von i.v. Prostaglandin E1 bei Diabetikern mit pAVK im Stadium IV.
VASA 35 (Suppl.).
1994;
164-166
-
18
Stockl K, Vanderplas A, Tafesse E, Chang E.
Costs of lower-xtremity ulcers among patients with diabetes.
Diabetes Care.
2004;
27
2129-2134
-
19
Stratton IM, Adler AI, Neil HA. et al. .
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
BMJ.
2000;
321
405-412
-
20
Trautner C, Haastert B, Spraul M. et al. .
Unchanged incidence of lower-limb amputation in a German city, 19901998.
Diabetes Care.
2001;
24
855-859
-
21
Wagner FW.
The dysvasculary foot: A system for diagnosis and treatment.
Foot and Ankle.
1981;
2
64-112
Korrespondenz
Dr. med. Alexandra Müller-Öffner
Städtisches Klinikum München GmbH, Klinikum Bogenhausen, Klinik für Endokrinologie, Diabetologie und Angiologie
Englschalkinger Straße 77
81925 München
Fax: 089/9270-2885
eMail: Alexandra.Oeffner@kh-bogenhausen.de
